 |
Discovering new classes of medicines that have unique modes of action to result in drugs with differentiated therapeutic properties. |
Private |
2012 |
View Profile |
 |
Discovering and developing novel drugs in the fields of cancer metabolism and rare metabolic genetic diseases. |
Private |
2007 |
View Profile |
 |
Discovering and developing innovative products that will transform the prevention and treatment of infectious diseases. |
Private |
2008 |
View Profile |
 |
Developmental biology insights for regenerative medicine therapies |
Acquired |
1994 |
View Profile |
 |
Developing therapeutic candidates for the treatment of immune and metabolic diseases. |
Public |
2009 |
View Profile |
 |
Developing resolvins, a novel class of therapies to treat inflammatory diseases and their complications. |
Private |
2005 |
View Profile |
 |
Developing powerful platform technologies and products for partners in the pharmaceutical, industrial, agricultural, and consumer sectors. |
Private |
2009 |
View Profile |
 |
Developing novel therapeutics to promote vascular repair. |
Private |
2003 |
View Profile |
 |
Developing novel protein measurement systems based on Protien Epitope Tag technology |
Acquired |
2003 |
View Profile |
 |
Developing new class of therapeutic compounds. |
Acquired |
2002 |
View Profile |
 |
Developing innovative technology for the low-cost conversion of abundant biomass. |
Private |
2006 |
View Profile |
 |
Developing ground-breaking tools in high definition diagnostics. |
Private |
2007 |
View Profile |
 |
Developing electronic design automation tool for high-performance virtual system prototypes |
Private |
2002 |
View Profile |
 |
Developing deliciously edible forms of packaging that enclose food or drinks in ways similar to how nature protects foods. |
Private |
2012 |
View Profile |
 |
Developing biologics to target autoimmune/inflammatory diseases. |
Private |
2006 |
View Profile |
 |
Developing and manufacturing revolutionary, low-cost, high-performance flow cytometers for researchers. |
Acquired |
2008 |
View Profile |
 |
Developing and commercializing IV therapy products. |
Private |
2011 |
View Profile |
 |
Developing an entirely new class of targeted vaccines that induces an antigen-specific immune activation or antigen-specific immune tolerance for therapeutic and prophylactic applications. |
Private |
2008 |
View Profile |
 |
Developing an array of products based on the company's proprietary TAP™ (Touch Activated Phlebotomy) painless blood collection platform. |
Private |
2007 |
View Profile |
.png) |
Developing activity-based costing systems for healthcare providers. |
Private |
2010 |
View Profile |
